Roquette

Last updated January 31, 2026

Innovation Areas

531

Inventors

Collaborations

Interlinked polysaccharide matrix architecture: RoquetteRecent Research Landscape

Uncontrolled drug release rates in topical and oral applications lead to poor bioavailability and systemic side effects. These innovations engineer the polymer network density to stabilize dosage forms and ensure sustained therapeutic delivery.

What technical problems is Roquette addressing in Interlinked polysaccharide matrix architecture?

Premature upper gastrointestinal degradation

(5)evidences

Therapeutic proteins suffer from rapid degradation and poor absorption across the intestinal epithelium. Overcoming these barriers ensures systemic therapeutic efficacy from oral administration.

Uncontrolled active ingredient release

(2)evidences

Dermal inflammation and associated barrier failure represent a physiological limitation in skin health. Addressing this specific pathology provides a therapeutic advantage over standard topical hydration.